Preparing Benefits For the Next Wave: Gene Therapy Medications
The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges.
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis.
Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the class of targeted cancer therapies called antibody drug conjugates.
Garner Health Secures $100M to Connect Patients with High-Performing Doctors
Garner's Series E round was led by Index Ventures with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund and Kaiser Permanente Ventures.
The EHR Was Built to Store Data — It Wasn’t Built to Orchestrate Care
The next evolution in digital health is layering intelligent orchestration on top of the EHR to activate care in real time. It’s a platform plus orchestration layer, powered by AI and designed for action.